OncoMethylome Sciences Reinforces U.S. Presence with Key Executive Appointments
OncoMethylome Sciences SA announced the appointments of Dr. Melissa A. Thompson as Vice President regulatory affairs and quality assurance, and of Mr. Christopher (Chris) Thibodeau as Vice President Commercial Operations.
Dr. Jan Groen, Chief Executive Officer of OncoMethylome, said: "With extensive experience in the molecular diagnostics space in the U.S., Melissa and Chris will be instrumental in expanding our presence in the U.S. market. They will both play a key role in developing and executing our new strategy, providing invaluable knowledge of the regulatory and commercialization processes. "
Melissa Thompson has more than 25 years of experience in the pharmaceutical, medical device, and molecular diagnostics industries. She has provided extensive consultative services in diagnostics to leading companies such as Johnson & Johnson, Wyeth, Inverness, and Affymetrix, as well start-ups like Signature Genomic Laboratories, Prognomix, Allegro Diagnostics, and ExonHit Therapeutics. She has fostered multiple products through U.S. Food and Drug Administration approval, and has additional background in clinical research and clinical trial design. Melissa Thompson holds a Ph.D. in Organizational Management from Concordia University and an MBA from Temple University, Philadelphia, PA.
Christopher Thibodeau brings over 15 years of sales, marketing and commercial leadership experience in the diagnostics arena. As Vice President Commercial Operations, he is responsible for developing and executing OncoMethylome's key strategic sales & marketing and business development initiatives. Prior to joining OncoMethylome he served as Senior Director of Marketing at Agendia Inc., Vice President of Sales and Marketing for Numira Biosciences, National Director of Sales US LABS (an industry leader in cancer diagnostic and genomic testing services); and a number of sales and marketing management roles at Ventana Medical. Chris Thibodeau holds a BSc degree from the East Stroudsburg University in Pennsylvania and studied French at the Faculté des Lettres in Nancy, France.
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
